Syra Health Corp financial data

Symbol
SYRA on Nasdaq
Industry
Services-Employment Agencies
Location
1119 Keystone Way N., #201, Carmel, IN
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 425 %
Debt-to-equity 33 %
Return On Equity -132 %
Return On Assets -99.2 %
Operating Margin -54.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.97M shares -35.5%
Weighted Average Number of Shares Outstanding, Basic 7.26M shares +66.6%
Weighted Average Number of Shares Outstanding, Diluted 7.26M shares +66.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.75M USD +47.5%
Revenue from Contract with Customer, Excluding Assessed Tax 7.74M USD +42.5%
Research and Development Expense 34.8K USD
Operating Income (Loss) -4.25M USD -25%
Nonoperating Income (Expense) -745 USD
Net Income (Loss) Attributable to Parent -4.25M USD -17.8%
Earnings Per Share, Basic -0.65 USD/shares +25%
Earnings Per Share, Diluted -0.65 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.24M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.05M USD
Other Assets, Current 483K USD +196%
Assets, Current 4.06M USD +229%
Property, Plant and Equipment, Net 34.6K USD -62.1%
Operating Lease, Right-of-Use Asset 325K USD +246%
Assets 4.43M USD +69.7%
Accounts Payable, Current 213K USD
Accrued Liabilities, Current 310K USD +12.8%
Liabilities, Current 878K USD -63.1%
Operating Lease, Liability, Noncurrent 217K USD
Liabilities 1.09M USD -71.5%
Retained Earnings (Accumulated Deficit) -8.32M USD -104%
Stockholders' Equity Attributable to Parent 3.33M USD
Liabilities and Equity 4.43M USD +69.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -801K USD -1677%
Net Cash Provided by (Used in) Financing Activities 764K USD +18%
Net Cash Provided by (Used in) Investing Activities -5.62K USD +41.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.1K USD -107%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.7M USD +14878%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.08K USD -58.6%
Deferred Tax Assets, Valuation Allowance 1.03M USD +210%
Deferred Tax Assets, Gross 1.03M USD +210%
Operating Lease, Liability 325K USD +246%
Depreciation 67.8K USD +107%
Payments to Acquire Property, Plant, and Equipment 5.62K USD -41.8%
Lessee, Operating Lease, Liability, to be Paid 370K USD +284%
Operating Lease, Liability, Current 109K USD +15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 135K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 135K USD +109%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +52.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 44.4K USD +1857%
Lessee, Operating Lease, Liability, to be Paid, Year Three 101K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.6M USD +310%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 4.08K USD -64.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%